ea0041gp112 | Endocrine Tumours | ECE2016
Herrera-Martinez Aura D
, Gahete Manuel D
, Sanchez-Sanchez Rafael
, Salas Rosa Ortega
, Blanch Raquel Serrano
, Salvatierra Juan
, Luque Raul
, Moreno Maria A Galvez
, Castano Justo P
Neuroendocrine tumors (NETs) are uncommon neoplasms with increasing incidence and limited therapeutic options, wherein identification of new diagnostic/prognostic/therapeutic biomarkers is urgently required. Alterations in somatostatin (SST)/cortistatin (CORT) and ghrelin systems have been associated to development/progression of several cancers. Thus, we evaluated expression levels of SST/CORT/ghrelin system components in gastroenteropancreatic-neuroendocrine tumors (GEP-NETs...